{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-093660","form_type":"8-K","ticker":"CGTX","cik":"0001455365","company_name":"COGNITION THERAPEUTICS INC","filed_at":"2024-08-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.109295+00:00","generated_at":"2026-05-31T07:09:20.166082+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Cognition Therapeutics furnishes investor presentation with no new material facts disclosed","bullets":["Filed an investor presentation under Item 7.01 on August 28, 2024.","Presentation cover titled 'Targeting Amyloid Beta Oligomers: A Disruptive Approach to the Treatment of Alzheimer’s Disease'.","No specific financial or clinical data from the presentation are included in the filing.","Presentation is furnished, not filed, and not incorporated by reference."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-093660","json":"https://secwatch.observer/filing/0001104659-24-093660.json","markdown":"https://secwatch.observer/filing/0001104659-24-093660.md","text":"https://secwatch.observer/filing/0001104659-24-093660.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1455365/000110465924093660/0001104659-24-093660-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1455365/000110465924093660/tm2422819d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T07:09:20.166082+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}